Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the drug infusion systems market right now?
In recent years, the size of the drug infusion systems market has witnessed robust growth. It is anticipated that the market will expand from $13.42 billion in 2024 to $14.34 billion in 2025, marking a compound annual growth rate (CAGR) of 6.9%. The surge in growth during the historical period can be ascribed to factors such as the transition to electronic infusion devices, a rise in chronic disease incidence, advancements in patient care, the advent of home-based infusion therapy, and the proliferation of ambulatory care settings.
How fast Is the drug infusion systems market expected to grow, and what’s its future value?
The market size for drug infusion systems is predicted to experience a significant increase in the forthcoming years, reaching a value of $20.46 billion in 2029 with a compound annual growth rate (CAGR) of 9.3%. The surge in the predicted timeframe can be accredited to a shift towards disposable systems, a rising incidence of chronic diseases, expansion of outpatient medical facilities, personalized therapy and adaptive dosing, alongside a growing need for home-based care. The major trends in the forecasted period encompass wireless connectivity and remote monitoring, integration into electronic health records (ehr), advancement in smart pump technology, personalized and adaptive dosing, and the development of minimally invasive infusion techniques.
Get your drug infusion systems market report here!
https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report
What are the leading drivers of growth in the drug infusion systems market?
The drug infusion system market is anticipated to expand due to the escalating prevalence of chronic illnesses. Diseases such as cancer, diabetes, cardiovascular disease, and autoimmune disorders often necessitate prolonged or ongoing infusion therapy, which drug infusion systems facilitate in a secure, efficient, and effective manner. Deviations in disease prevalence have been more rapid in low- to middle-income countries compared to wealthier nations. For example, diabetes, a leading cause of renal failure, heart attacks, strokes, blindness, and lower limb amputation, is increasing. In America, a growing percentage of the population is dealing with multiple chronic diseases, as indicated by CDC reports from February 2024. These reports show that 42% have two or more chronic conditions, while 12% have five or more. Consequently, the escalating need due to the widespread prevalence of chronic diseases contributes to the expansion of the drug infusion system market.
What are the key segments defining the drug infusion systems market?
The drug infusion systems market covered in this report is segmented –
1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System
2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration
3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users
Subsegments:
1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps
2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components
3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps
4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps
5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies
6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps
7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps
8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp
Who are the key players steering the development of the drug infusion systems market?
Major companies operating in the drug infusion systems market include Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc.
What emerging trends are influencing the growth of the drug infusion systems market?
Key players in the drug infusion systems market, like Eitan Medical, are innovating by creating technology like cloud-based infusion management systems to augment patient care and increase precision, ultimately streamlining the process of managing infusion therapies. These systems are digital platforms that utilize cloud technology for administering, tracing, and supervising medication infusions. For example, Eitan Medical, a prestigious American company specializing in infusion therapy and drug delivery, introduced Eitan Insights in June 2023 – a cloud-based infusion management system specifically built for the varied needs of home and specialty infusions. Eitan Insights offers real-time data and analysis to healthcare professionals, giving them the ability to remotely oversee patients and revise treatment plans as required. By diminishing the likelihood of errors and improving adherence to designated protocols, this system reinforces medication safety.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10703
Which regions are most influential in expanding the drug infusion systems market?
North America was the largest region in the drug infusion systems market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Cardiovascular Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report
Metabolic Disorders Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report
Dermatology Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
